𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Monoamine oxidase inhibition and neuroprotection by N1-propargylphenelzine

✍ Scribed by B. Duff Sloley; Liana J. Urichuk; Ling Lei; Ronald T. Coutts; Glen B. Baker; Jaqueline J. Shan; Peter K.T. Pang


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
120 KB
Volume
53
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Neurotoxins and monoamine oxidase inhibi
✍ Prof. K. T. Finnegan πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 675 KB

Recent clinical studies suggest that selegiline (1.-deprenyl) is useful in retarding the progress of Parkinson's disease. an effect that may bc related to its inhibition of monoamine oxidase type B (MAO-B). Selegilinc is also reported to prevent the toxic effects of the norddrenergic neurotoxin, h~-

REM sleep and central monoamine oxidase
✍ David J. Kupfer; Malcolm B. Bowers πŸ“‚ Article πŸ“… 1972 πŸ› Springer 🌐 English βš– 454 KB

Our preliminary observations on the relationship of sleep and lumbar CSF acid monoamine metabolite levels suggested a greater decrease in lumbar CSF HVA as compared to 5HIAA following clinical doses of phenelzine in the presence of virtually total REM suppression. This report on nine psychiatric pat